Mimori K - Search Results

1

Biological and clinical availability of adipose-derived stem cells for pelvic dead space repair.

Takahashi H, Haraguchi N, Nishikawa S, Miyazaki S, Suzuki Y, Mizushima T, Nishimura J, Takemasa I, Yamamoto H, Mimori K, Ishii H, Doki Y, Mori M. Takahashi H, et al. Among authors: mimori k. Stem Cells Transl Med. 2012 Nov;1(11):803-10. doi: 10.5966/sctm.2012-0085. Epub 2012 Oct 23. Stem Cells Transl Med. 2012. PMID: 23197692 Free PMC article.

2

[Recent advances in the diagnosis and treatment of colorectal cancers].

Mimori K, Mori M. Mimori K, et al. Nihon Geka Gakkai Zasshi. 2002 Jun;103(6):468-71. Nihon Geka Gakkai Zasshi. 2002. PMID: 12094697 Japanese.

3

Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M. Mimori K, et al. Oncology. 2002;62(4):327-32. doi: 10.1159/000065064. Oncology. 2002. PMID: 12138240

4

A single-nucleotide polymorphism of SMARCB1 in human breast cancers.

Mimori K, Inoue H, Shiraishi T, Ueo H, Mafune K, Tanaka Y, Mori M. Mimori K, et al. Genomics. 2002 Sep;80(3):254-8. doi: 10.1006/geno.2002.6829. Genomics. 2002. PMID: 12213194

5

Prognostic score of gastric cancer determined by cDNA microarray.

Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M. Inoue H, et al. Among authors: mimori k. Clin Cancer Res. 2002 Nov;8(11):3475-9. Clin Cancer Res. 2002. PMID: 12429637

6

Clinical significance of the expression of activin A in esophageal carcinoma.

Yoshinaga K, Mimori K, Yamashita K, Utsunomiya T, Inoue H, Mori M. Yoshinaga K, et al. Among authors: mimori k. Int J Oncol. 2003 Jan;22(1):75-80. Int J Oncol. 2003. PMID: 12469187

7

INI-1, a partner gene of ALL-1, is highly conserved in human acute leukemia.

Mimori K, Inoue H, Ishii H, Mori M. Mimori K, et al. Oncol Rep. 2003 May-Jun;10(3):551-3. Oncol Rep. 2003. PMID: 12684622

8

Microsatellite instability is often observed in esophageal carcinoma patients with allelic loss in the FHIT/FRA3B locus.

Mimori K, Inoue H, Shiraishi T, Matsuyama A, Mafune K, Tanaka Y, Mori M. Mimori K, et al. Oncology. 2003;64(3):275-9. doi: 10.1159/000069317. Oncology. 2003. PMID: 12697969

9

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. Mimori K, et al. Oncogene. 2003 May 29;22(22):3463-71. doi: 10.1038/sj.onc.1206378. Oncogene. 2003. PMID: 12776198

10

Platelet-derived endothelial cell growth factor mediates Rho-associated coiled-coil domain kinase messenger RNA expression and promotes cell motility.

Yoshinaga K, Inoue H, Tanaka F, Mimori K, Utsunomiya T, Mori M. Yoshinaga K, et al. Among authors: mimori k. Ann Surg Oncol. 2003 Jun;10(5):582-7. doi: 10.1245/aso.2003.08.020. Ann Surg Oncol. 2003. PMID: 12794027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

513 results

Search Page

Filters